Stage III Colorectal Cancer: Pete's Survivor Story

Patient Info: Pete Di Stefano, 40s | Stage III

Completed surgery and 3 months of FOLFOX chemotherapy for Stage IIIB transverse colon cancer; latest NED status is not reported, so this is best classified as survivorship / surveillance.

Fight Colorectal CancerRead more →

Stage III Colorectal Cancer: Karina's Survivor Story

Patient Info: Karina Bandera, Female, 40s | Stage III

Recovering after treatment for Stage IIIC rectal cancer, including chemotherapy, surgery, sepsis complication, ileostomy, more chemotherapy, and ileostomy reversal; she reported doing well, but explicit NED/remission status is not stated.

Fight Colorectal CancerRead more →

Stage III ALK Non-Small Cell Lung Cancer: Michelle's Patient Story

Patient Info: Michelle Bos-Lun, Female | Stage III

Biomarkers: ALK-positive

Stage IIIB ALK-positive lung cancer responding to Lorbrena/lorlatinib, with cough improvement within days and first scan showing nearly 50% tumor reduction.

GO2 FoundationRead more →

Stage III EGFR Non-Small Cell Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage III

Biomarkers: EGFR mutation

No evidence of cancer on 1-year scan after fertility preservation, chemotherapy, radiation, and removal of half the left lung for Stage III EGFR-mutated lung cancer.

Lung Cancer Research FoundationRead more →

Stage III ROS1 Non-Small Cell Lung Cancer: Wendy's Survivor Story

Patient Info: Wendy, Female | Stage III

Biomarkers: ROS1-positive / ROS1-rearranged

Completed chemoradiation, surgery, and post-surgery radiation for Stage III ROS1-positive NSCLC by January 2017 and later shared a long-term survivor/advocacy story; no explicit NED statement is given.

Lung Cancer Research FoundationRead more →

Stage III Colorectal Cancer: Kevin's Survivor Story

Patient Info: Kevin, Male, 50s | Stage III

Biomarkers: Tumor DNA used to create custom blood test for ctDNA monitoring; no actionable biomarker reported

No issues or signs of recurrence 2.5 years after finishing chemotherapy, with clean colonoscopy 1 year after surgery and ongoing liquid-biopsy monitoring.

Colorectal Cancer AllianceRead more →

Stage III Breast Cancer: Cher's Survivor Story

Patient Info: Cher, Female | Stage III

Biomarkers: Hormone-positive; HER2-negative; Oncotype DX score 0

No evidence of disease after treatment for Stage IIIB breast cancer, with ongoing adjuvant Verzenio, long-term hormone blockers, and planned preventive mastectomy/DIEP flap reconstruction.

breastcancer.orgRead more →

Stage III Colorectal Cancer: Gabriel's Survivor Story

Patient Info: Gabriel Leblanc, Male, Under 40 | Stage III

Stage III colon cancer survivor who avoided an ostomy after total colectomy, completed chemotherapy, returned to full-time work, and is described in the source as moving from Stage III to NED.

Colorectal Cancer AllianceRead more →

Stage III Colorectal Cancer: Nick's Survivor Story

Patient Info: Nick Cleworth, Male, 40s | Stage III

Cancer-free after ARTEMIS clinical-trial treatment for node-positive rectal cancer, avoiding surgery and a permanent colostomy.

The Christie NHSRead more →

Stage III Lung Adenocarcinoma: Becky's Survivor Story

Patient Info: Becky Manning, Female, 40s | Stage III

After surgery, chemotherapy and 8 months of nivolumab on a clinical trial, Becky was no longer on active treatment, had no evidence of disease, felt well, and returned to MSK every 6 months for follow-up.

Memorial Sloan KetteringRead more →

Sexual safety during FOLFOX treatment for Stage III rectal cancer

Patient Info: Anonymized, female, 50s | Stage III

A 54-year-old woman with Stage III rectal cancer raised a practical sexual-health question while receiving FOLFOX, leading to direct measurement of oxaliplatin exposure in vaginal secretions.

PubMed CentralRead more →

Stage III Triple-Negative Breast Cancer: Cookie's Survivor Story

Patient Info: Cookie Joe, female | Stage III

Biomarkers: triple-negative

More than 5 years after her April 2021 diagnosis, she remains cancer-free (since December 2022) and continues breast-cancer advocacy, fundraising, and blood-donation efforts.

MD AndersonRead more →

HER2-positive breast cancer complicated by severe anemia during chemotherapy

Patient Info: Anonymized, female, 40s | Stage III

Biomarkers: ER-negative; PR-negative; HER2-positive; germline BRCA1 likely pathogenic mutation

At 4.5-year follow-up, she remained free of breast-cancer recurrence and had no recurrence of the severe treatment-related anemia.

PubMed CentralRead more →

Stage III Invasive Lobular Carcinoma: Betsy's Patient Story

Patient Info: Betsy | Stage III

Betsy continues long-term hormone therapy with anastrozole after almost 2 years of tamoxifen.

Lobular Breast Cancer AllianceRead more →

Stage III MSI-High Colorectal Adenocarcinoma: Briana's Survivor Story

Patient Info: Briana Ghbein, Under 40 | Stage III

Biomarkers: MSH2 mutation, dMMR/MSI-H

Postoperative pathology after her 2024 treatment showed no evidence of disease.

Fight Colorectal CancerRead more →

Stage III Invasive Lobular Carcinoma: Famke's Survivor Story

Patient Info: Famke, Female, Under 40 | Stage III

Famke received surgery, chemotherapy and radiation and celebrated 5 years since diagnosis while continuing long-term hormone therapy.

Lobular Breast Cancer AllianceRead more →

Stage IIIB lung cancer: heart inflammation from durvalumab immunotherapy, mistaken at first for tumor spreading to the heart

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: No actionable driver mutations identified; PD-L1 tumor proportion score <1%

She recovered cardiac function after treatment for durvalumab-associated myocarditis and remained without lung-cancer relapse or cardiac decline for more than 4 years, with no additional anticancer therapy.

PubMed CentralRead more →

Stage III Colorectal Cancer: Michael's Survivor Story

Patient Info: Michael Ettinger, Under 40 | Stage III

Michael reported that he was approaching his 5-year cancer-free anniversary in October 2026.

Fight Colorectal CancerRead more →

Stage III HR-Positive Invasive Ductal Carcinoma: Stefanie's Survivor Story

Patient Info: Stefanie, Female | Stage III

Biomarkers: ER-positive, PR-positive and HER2-positive

Stefanie completed chemotherapy, breast-conserving surgery, prolonged Herceptin and 30 radiation treatments, then moved into survivorship while still adjusting to the lasting effects of treatment.

The Patient StoryRead more →

Paul Weigel

Patient Info: Paul Weigel, Male, 40s | Stage III

Paul completed treatment, returned to endurance athletics, and later became a colorectal cancer advocate and author.

Fight Colorectal CancerRead more →

Stage III Lung Adenocarcinoma: Heidi's Survivor Story

Patient Info: Heidi Nafman-Onda, Female, 50s | Stage III

Heidi described living 3 years after a Stage III lung adenocarcinoma diagnosis with a high quality of life and became a lung cancer awareness advocate through The White Ribbon Project.

The Patient StoryRead more →

Stage III Inflammatory Breast Cancer: Rhonda's Patient Story

Patient Info: Rhonda Holbert, Female | Stage III

Rhonda survived inflammatory breast cancer and later lived with significant long-term health effects while continuing to support and advocate for other people with cancer.

Hormone receptor-positive, HER2-positive breast cancer treatment interrupted by vaginal cuff dehiscence and bowel evisceration

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: Hormone receptor-positive; HER2-positive

At 21 months after emergency repair, she was symptom-free with POP-Q stage 0; letrozole continued and T-DM1 was resumed 7 weeks after discharge, but long-term cancer response was not detailed.

PubMed CentralRead more →

Stage III Colorectal Cancer: Zed's Survivor Story

Patient Info: Zed, Male, Under 40 | Stage III

Biomarkers: Lynch syndrome

As of June 2026, Zed had completed colectomy and chemotherapy and was in surveillance with no evidence of disease. Lynch syndrome was also identified, supporting stricter long-term surveillance.

The Patient StoryRead more →